Placebo-Controlled Study Finds Psilocybin Formulation is Safe and Well-Tolerated in Healthy Volunteers
The study used an investigational psilocybin formulation called COMP360 developed and produced by COMPASS Pathways.
The study used an investigational psilocybin formulation called COMP360 developed and produced by COMPASS Pathways.
These bluing compounds can exist as dimeric, trimeric, and tetrameric forms of psilocin and/or its structural analogs.
A recent Nature paper provides novel insights into the neural correlates of the Breakthrough Experience associated with DMT.
Identifying and understanding prodrugs is an essential component of psychedelic drug research.
The study will examine the effects of microdosing LSD on the everyday lives of the participants.
Coming on the heels of the passing of their magic mushroom decriminalization measure in May, the city of Denver, Colorado has created the world’s first Psilocybin Mushroom Policy Review Panel...
A look into the promising potential of artificial intelligence in tackling unmet medical needs in mental healthcare
Psychedelics disrupt the brain networks responsible for the feeling of selfhood.
This new crystal form presents new options for developing psychedelics into therapeutic drug formulations.
Crystal structures help researchers understand changes at the molecular level that affect the physical properties of compounds.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.